You have 9 free searches left this month | to do more
Showing 1 - 25 of
1,026 items
Did you mean:
Trials Per Page
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
R
Study of R289 in Patients With Lower-risk Myelodysplastic Syndromes (LR MDS)
Not yet recruiting
  • Low Risk Myelodysplastic Syndromes
  • R906289 Monosodium (R289 Na)
  • (no location specified)
2022-03-25
Mar 25, 2022
C
Immunoevasive Tactics Employed by Myeloid Malignancy After Allogeneic Stem Cell Transplantation
Not yet recruiting
  • Relapse Leukemia
  • +2 more
  • blood sample
  • bone marrow sample
  • (no location specified)
2019-05-24
May 24, 2019
A
Study Of Venetoclax Tablet With Intravenous or Subcutaneous Azacitidine to Assess Change in Disease Activity In Adult Participants With Newly Diagnosed Higher-Risk Myelodysplastic Syndrome
Recruiting
  • Myelodysplastic Syndrome (MDS)
  • Birmingham, Alabama
  • +221 more
2022-03-08
Mar 8, 2022
G
A Study of Azacitidine in Myelodysplastic Syndrome (MDS) Associated to Systemic Auto-immune and Inflammatory Disorders
Active, not recruiting
  • MDS
  • Systemic Autoimmune Diseases
  • Amiens cedex 01, France
  • +58 more
2021-10-11
Oct 11, 2021
S
Tolerability and Efficacy of Midostaurin to 10-day Decitabine in Unfit Adult AML and High Risk MDS Patients
Active, not recruiting
  • AML/MDS
  • Antwerpen, Belgium
  • +36 more
2021-12-29
Dec 29, 2021
B
A Phase Ib/II Multicenter Open-label Study of Bemcentinib (BGB324) in Patients With AML or MDS
Active, not recruiting
  • Acute Myeloid Leukemia
  • Myelodysplastic Syndromes
  • Iowa City, Iowa
  • +11 more
2022-03-01
Mar 1, 2022
C
Advanced Translational Research on Childhood Leukemia
Recruiting
  • Childhood Leukemia
  • RNA-seq
  • +2 more
  • Hong Kong, Hksar, China
    Hong Kong Children Hospital
2021-07-26
Jul 26, 2021
I
GENOMED4ALL: Improving MDS Classification and Prognosis by AI
Active, not recruiting
  • Myelodysplastic Syndromes
    • Milano, Italy
      Istituto Clinico Humanitas
    2021-06-28
    Jun 28, 2021
    U
    Investigation of the Gut Microbiota in Patients With Acute Myeloid Leukemia - 2020
    Completed
    • Acute Myeloid Leukemia
    • Cachexia
    • collection of clinical data and biological samples
    • Brussels, Belgium
      UCLouvain
    2021-09-21
    Sep 21, 2021
    G
    Treatment of High Risk Myelodysplastic Syndromes (MDS) Not Candidates for Allogeneic Transplantation of Hematopoietic Progenitors (ALO-HSCT)
    Recruiting
    • Myelodysplastic Syndromes
    • Azacitidine Injection [Vidaza]
    • Palma, Islas Baleares, Spain
      Son Llàtzer
    2020-10-20
    Oct 20, 2020
    S
    Efficacy and Safety of Micafungin for Injection in Prevention and Treatment of Fungal Infection in Hematological Tumors
    Recruiting
    • Hematological Tumors Patients With High Risk Factors of Invasive Fungal Disease
    • Micafungin Sodium
    • Jinan, Shandong, China
      Department of Hematology, Provincial Hospital Affiliated to Shan
    2021-02-01
    Feb 1, 2021
    R
    MiHA-loaded PD-L-silenced DC Vaccination After Allogeneic SCT - 2021
    Completed
    • Hematological Malignancies
    • MiHA-loaded PD-L-silenced DC Vaccination
    • Nijmegen, Gelderland, Netherlands
      Trialoffice Haematology-Oncology
    2021-03-31
    Mar 31, 2021
    F
    Removal of Doravirine by Hemodialysis in HIV-Infected Patients With End-stage Renal Disease (ESRD) - 2021
    Completed
    • HIV-infected Participants With ESRD Undergoing Routine Hemodialysis
    • Badalona, Barcelona, Spain
    • +2 more
    2021-07-06
    Jul 6, 2021
    P
    Safety and Efficacy of Dexmedetomidine (DEX) for Sedation of Subjects ≥1 Month to <17 Years Undergoing MRI Scans - 2021
    Completed
    • MRI Sedation
    • Little Rock, Arkansas
    • +22 more
    2022-02-22
    Feb 22, 2022
    G
    A Dose Confirmation Study of Oral Clofarabine for Adult Patients Previously Treated for Myelodysplastic Syndromes (MDS) - 2011
    Completed
    Has Results
    • Myelodysplastic Syndromes
    • Secondary Acute Myeloid Leukemia (AML)
    • Chicago, Illinois
    • +5 more
    2022-03-15
    Mar 15, 2022
    M
    Daratumumab in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome
    Active, not recruiting
    • High Risk Myelodysplastic Syndrome
    • +2 more
    • Daratumumab
    • Houston, Texas
      M D Anderson Cancer Center
    2022-03-01
    Mar 1, 2022
    G
    Tagraxofusp in Patients With CD123+ or With BPDCN-IPh-like Acute Myeloid Leukemia
    Recruiting
    • Acute Myeloid Leukemia
    • Bergamo, Italy
    • +7 more
    2021-12-17
    Dec 17, 2021
    W
    Investigator Initiated Trial of CPX-351 for Untreated Acute Myeloid Leukemia
    Active, not recruiting
    • Leukemia, Myeloid, Acute
    • New York, New York
      Weill Cornell Medical College
    2021-12-10
    Dec 10, 2021
    I
    Immunogenicity of Influenza Vaccine in Long Term Care
    Active, not recruiting
    • Influenza
    • Blood Draw
    • Cleveland, Ohio
      Case Western Reserve University
    2021-03-08
    Mar 8, 2021
    Q
    Study on the Mode and Mechanism of Ultra-low Frequency rTMS for Sleep Disorders in Patients With Parkinson's Disease
    Enrolling by invitation
    • Repetitive Transcranial Magnetic Stimulation
    • +2 more
    • Ultra-low frequency repetitive transcranial magnetic stimulation
    • Jinan, Shandong, China
      The First Affiliated Hospital of Shandong First Medical Universi
    2021-03-20
    Mar 20, 2021
    S
    Efficacy and Safety of Cladribine in Combination With CAG in Newly Diagnosed Unfit Patients With AML
    Not yet recruiting
    • Acute Myeloid Leukemia
    • +2 more
    • Cladribine Injection
    • +3 more
    • Guangzhou, Guangdong, China
      Sun Yat-sen University Cancer Center
    2020-12-15
    Dec 15, 2020
    G
    CPX-351 in Higher Risk Myelodysplastic Syndromes
    Active, not recruiting
    • Myelodysplastic Syndromes
    • CPX-351 in cohort A
    • CPX-351 in cohort B
    • Amiens, France
    • +15 more
    2022-03-09
    Mar 9, 2022
    G
    Magrolimab Monotherapy or Magrolimab in Combination With Azacitidine in Participants With Hematological Malignancies
    Active, not recruiting
    • Hematological Malignancies
    • Duarte, California
    • +26 more
    2022-02-03
    Feb 3, 2022
    A
    LCI-BRE-MTN-NIR-001:Ph I Study of Niraparib in Combo With Standard Chemo in Metastatic Trip Neg Breast Cancer
    Withdrawn
    • Breast Cancer
    • (no location specified)
    2021-05-30
    May 30, 2021
    U
    iCare 2: Personalized Genomic Mutation Informed Treatment of Patients With Myelodysplastic Syndromes
    Withdrawn
    • Myelodysplastic Syndromes
    • FDA-approved drug or combination of drugs
    • +5 more
    • Gainesville, Florida
      University of Florida
    2019-06-07
    Jun 7, 2019